Yasuo Saijo

Gefitinib or Chemotherapy for Non–Small-Cell Lung Cancer with Mutated EGFR

Makoto Maemondo, Akira Inoue, Kunihiko Kobayashi et al. · New England Journal of Medicine · 2010 · 5.5K citations

Updated overall survival results from a randomized phase III trial comparing gefitinib with carboplatin–paclitaxel for chemo-naïve non-small cell lung cancer with sensitive EGFR gene mutations (NEJ002)

Akira Inoue, Kunihiko Kobayashi, Makoto Maemondo et al. · Annals of Oncology · 2012 · 549 citations

Oncology, Pathology, Cancer Treatment +6

First-Line Gefitinib for Patients With Advanced Non–Small-Cell Lung Cancer Harboring Epidermal Growth Factor Receptor Mutations Without Indication for Chemotherapy

Akira Inoue, Kunihiko Kobayashi, Kazuhiro Usui et al. · Journal of Clinical Oncology · 2009 · 515 citations

Prospective Phase II Study of Gefitinib for Chemotherapy-Naïve Patients With Advanced Non–Small-Cell Lung Cancer With Epidermal Growth Factor Receptor Gene Mutations

Akira Inoue, Takuji Suzuki, Tatsuro Fukuhara et al. · Journal of Clinical Oncology · 2006 · 503 citations · Full text

Severe acute interstitial pneumonia and gefitinib

Akira Inoue, Yasuo Saijo, Makoto Maemondo et al. · The Lancet · 2003 · 452 citations

Antibiotics, Acute Care, Interstitial Pneumonia +3